Read comments that SAMHSA received in response to possible changes to substance abuse confidentiality regulations.
Protecting the confidentiality of patient information is critical in substance use disorder treatment. Without adequate protection, clients may avoid treatment if they are concerned that their diagnosis or treatment information will be disclosed without their consent. Confidentiality is governed by the Confidentiality of Alcohol and Drug Abuse Patient Records, 42 Code of Federal Regulations (CFR) Part 2 which outlines how patient information is protected and under what circumstances that information may be disclosed. Regulation 42 CFR Part 2 applies to any federally assisted program that holds itself out as providing and provides substance use disorder diagnosis, treatment, or referral for treatment.
In June 2014, SAMHSA held a listening session to seek feedback on potential changes to the regulations. SAMHSA also invited stakeholders to submit their comments in writing.
Read the comments that SAMHSA received:
- Comments_1-49 (PDF | 4.6 MB)
- Comments_50-54N (PDF | 7.9 MB)
- Comments_54P-99 (PDF | 9.4 MB)
- Comments_100-120 (PDF | 17.6 MB)
- Comments_121-144 (PDF | 4.8 MB)
- Comments_145AA-145NS (PDF | 264 KB)
- Comments_145CA-EZ (PDF | 133 KB)
- Comments_145FA-HZ (PDF | 208 KB)
- Comments_145IA-LZ (PDF | 175 KB)
- Comments_540-145NU (PDF | 478 KB)